Eiger Biopharmaceuticals Inc buy Reibach111
Start price
23.07.17
/
50%
€8.79
Target price
11.01.18
€13.53
Performance (%)
53.85%
End price
11.01.18
€13.53
Summary
This prediction ended on 11.01.18 with a price of €13.53. The BUY prediction by Reibach111 for Eiger Biopharmaceuticals Inc saw massive gains of 53.85%. Reibach111 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Eiger Biopharmaceuticals Inc | - | - | - | - |
| iShares Core DAX® | -1,76 % | 1,67 % | 2,10 % | 51,75 % |
| iShares Nasdaq 100 | 2,32 % | 12,78 % | 38,81 % | 96,06 % |
| iShares Nikkei 225® | 5,02 % | 13,30 % | 60,10 % | 71,80 % |
| iShares S&P 500 | 0,80 % | 6,20 % | 25,36 % | 68,52 % |
Comments by Reibach111 for this prediction
In the thread Eiger Biopharmaceuticals Inc diskutieren
Reibach111 stimmt dem Crowdsentiment von 'Buy' zu
Reibach111 stimmt am 23.07.2017 dem Buy-Crowdsentiment mit dem Kursziel 13.3$ zu.
(Zielkurs erreicht)


